Welsh Government: 'Robust process' underway
– Welsh Government spokespersonThe All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
Cartoonist's take on Welsh politics
The work of the cartoonist Mumph, taking a humorous look at Welsh politics over 30 years, is recognised at an exhibition in Caernarfon
Driver admits killing mother in Cardiff 'hit-and-run'
Karina Menzies, 31, died following the incident in the Ely area of the city on October 19.
'Mid-air drama' for royal couple ahead of Hay Festival
The two arrived late after their helicopter was forced to make an emergency landing minutes after taking off from central London.